Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

May 26, 2022

50715_rns_2022-05-26_3f0f36a0-5fc0-45de-b1ad-9953699cf66a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

26 May 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Description
of products
Nature of
dealings
Number of
reference
securities
to which
the
derivatives
relate
Maturity
date /
closing out
date
Reference
price
Total amount
paid / received
Resultant
balance
(including
those of any
person with
whom there is
an agreement
or
understanding)
China
International
Capital
Corporation
Limited
25 May 2022 Other types of
securities
Other types of
products
Closing out of a
derivative
contract
50,000 15 November
2022
$38.1172 $1,905,860.0000 400

End

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.